Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing (vol 5, vdad076, 2023)

被引：0
|
作者：
Farooqi, Midhat S.
机构：
来源：
NEURO-ONCOLOGY ADVANCES | 2023年 / 5卷 / 01期
关键词：
D O I：
10.1093/noajnl/vdad114
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 1 条
  • [1] Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing
    Galbraith, Kristyn
    Vasudevaraja, Varshini
    Serrano, Jonathan
    Shen, Guomiao
    Tran, Ivy
    Abdallat, Nancy
    Wen, Mandisa
    Patel, Seema
    Movahed-Ezazi, Misha
    Faustin, Arline
    Spino-Keeton, Marissa
    Roberts, Leah Geiser
    Maloku, Ekrem
    Drexler, Steven A.
    Liechty, Benjamin L.
    Pisapia, David
    Krasnozhen-Ratush, Olga
    Rosenblum, Marc
    Shroff, Seema
    Boue, Daniel R.
    Davidson, Christian
    Mao, Qinwen
    Suchi, Mariko
    North, Paula
    Hopp, Amanda
    Segura, Annette
    Jarzembowski, Jason A.
    Parsons, Lauren
    Johnson, Mahlon D.
    Mobley, Bret
    Samore, Wesley
    McGuone, Declan
    Gopal, Pallavi P.
    Canoll, Peter D.
    Horbinski, Craig
    Fullmer, Joseph M.
    Farooqui, Midhat S.
    Gokden, Murat
    Wadhwani, Nitin R.
    Richardson, Timothy E.
    Umphlett, Melissa
    Tsankova, Nadejda M.
    DeWitt, John C.
    Sen, Chandra
    Placantonakis, Dimitris G.
    Pacione, Donato
    Wisoff, Jeffrey H.
    Teresa Hidalgo, Eveline
    Harter, David
    William, Christopher M.
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
1